These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29312989)

  • 1. Corrigendum to "Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction".
    Ahmad I; Huang L; Hao H; Sanders P; Yuan Z
    Biomed Res Int; 2017; 2017():1408737. PubMed ID: 29312989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction.
    Ahmad I; Huang L; Hao H; Sanders P; Yuan Z
    Biomed Res Int; 2016; 2016():5465678. PubMed ID: 26989688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction".
    Benini A; Fumagalli GF
    Biomed Res Int; 2017; 2017():7698452. PubMed ID: 28804722
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.
    Toutain PL
    AAPS PharmSci; 2002; 4(4):E38. PubMed ID: 12646010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in the pharmaceutical industry: an IQ consortium survey examining the current landscape.
    Schuck E; Bohnert T; Chakravarty A; Damian-Iordache V; Gibson C; Hsu CP; Heimbach T; Krishnatry AS; Liederer BM; Lin J; Maurer T; Mettetal JT; Mudra DR; Nijsen MJ; Raybon J; Schroeder P; Schuck V; Suryawanshi S; Su Y; Trapa P; Tsai A; Vakilynejad M; Wang S; Wong H
    AAPS J; 2015 Mar; 17(2):462-73. PubMed ID: 25630504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
    Toutain PL; Lees P
    J Vet Pharmacol Ther; 2004 Dec; 27(6):467-77. PubMed ID: 15601441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
    Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
    Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
    Lees P; Giraudel J; Landoni MF; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Antibody-Drug Conjugate Development.
    Singh AP; Shin YG; Shah DK
    Pharm Res; 2015 Nov; 32(11):3508-25. PubMed ID: 25666843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research.
    Danhof M; de Lange EC; Della Pasqua OE; Ploeger BA; Voskuyl RA
    Trends Pharmacol Sci; 2008 Apr; 29(4):186-91. PubMed ID: 18353445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of pharmacokinetics-pharmacodynamics/clinical response modeling and simulation for biologics drug development.
    Zhao L; Shang EY; Sahajwalla CG
    J Pharm Sci; 2012 Dec; 101(12):4367-82. PubMed ID: 23018763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tools for predicting the PK/PD of therapeutic proteins.
    Diao L; Meibohm B
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1115-25. PubMed ID: 25936400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1).
    Singh AP; Shah DK
    AAPS J; 2017 Jul; 19(4):1054-1070. PubMed ID: 28374319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: A practical introduction to mechanistic modeling of disease transmission in veterinary science.
    Kirkeby C; Brookes VJ; Ward MP; Dürr S; Halasa T
    Front Vet Sci; 2023; 10():1129870. PubMed ID: 36756311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of mechanism-based PK/PD modeling in pharmacodynamic-based dose selection of muM17, a surrogate monoclonal antibody for efalizumab.
    Wu B; Joshi A; Ren S; Ng C
    J Pharm Sci; 2006 Jun; 95(6):1258-68. PubMed ID: 16637054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.
    Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA
    Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Support Vector Machine Weather Prediction Technology Based on the Improved Quantum Optimization Algorithm".
    Zhang J; Qiu X; Li X; Huang Z; Wu M; Dong Y
    Comput Intell Neurosci; 2022; 2022():9762403. PubMed ID: 35186074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of microdialysis for pharmacokinetic-pharmacodynamic modelling.
    Höcht C; Opezzo JA; Bramuglia GF; Taira CA
    Expert Opin Drug Discov; 2006 Sep; 1(4):289-301. PubMed ID: 23495900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.